Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
Citi
Healthtrust
US Department of Justice
Deloitte
Chubb
McKinsey
Harvard Business School
Mallinckrodt

Generated: August 17, 2017

DrugPatentWatch Database Preview

HUMATIN Drug Profile

« Back to Dashboard

Which patents cover Humatin, and when can generic versions of Humatin launch?

Humatin is a drug marketed by King Pfizer, Parkedale, and Parke Davis. and is included in three NDAs.

The generic ingredient in HUMATIN is paromomycin sulfate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the paromomycin sulfate profile page.

Summary for Tradename: HUMATIN

Patents:0
Applicants:3
NDAs:3
Bulk Api Vendors: see list39
Patent Applications: see list760
Drug Prices:see details
DailyMed Link:HUMATIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pfizer
HUMATIN
paromomycin sulfate
CAPSULE;ORAL062310-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parkedale
HUMATIN
paromomycin sulfate
CAPSULE;ORAL060521-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
HUMATIN
paromomycin sulfate
SYRUP;ORAL060522-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Moodys
US Department of Justice
Queensland Health
Farmers Insurance
McKesson
Chubb
Fuji
Deloitte
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot